FDA Advisory Committee Finds Data Support The Safety And Effectiveness Of NovoTTF-100A System
Novocure announced that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF ...

FDA Pains Migraine Sufferers
Roughly 30 million Americans suffer from painful and often disabling migraine headaches.

FDA Approves Zostavax Vaccine To Prevent Shingles In Individuals 50 To 59 Years Of Age
The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by ...